
ESMO/X
Jun 21, 2025, 08:25
Updated ESMO Clinical Practice Guideline Recommendations in the Non-oncogene-addicted Metastatic NSCLC
ESMO (European Society for Medical Oncology) shared a post on LinkedIn:
“Updated ESMO Clinical Practice Guideline recommendations in the non-oncogene-addicted metastatic NSCLC: new 1L Treatment options approved.”
Read OncoDaily’s Special Article: “Metastatic Lung Cancer: Causes, Symptoms, Treatment, and 2025 Advances in Therapy“
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 21, 2025, 06:35
Jun 21, 2025, 06:02
Jun 20, 2025, 16:37
Jun 20, 2025, 16:26